Clinical Cancer Research

American Association for Cancer Research

Evaluation status available after sign-in

About the journal

Clinical Cancer Research is a journal published by American Association for Cancer Research in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
American Association for Cancer Research
ISSN
1078-0432 · 1557-3265
Country
United States
Access
Not open access / not declared

Index listings

  • MEDLINE · 1965-01-01
  • PUBMED · 2003-08-01
Indexing
MEDLINE · PUBMED
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
132 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

27412

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

419

i10-index

15268

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Norwegian register (HK-dir)— 2027
Level 2 — top tier (~20% of the field's channels)
Open references deposited at Crossref
22%
ORCID iDs in current deposits
22%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9502500
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Advanced Breast Cancer Therapies
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics
Show all subjects (75)
  • Cancer Genomics and Diagnostics
  • Lung Cancer Treatments and Mutations
  • Immunotherapy and Immune Responses
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Ovarian cancer diagnosis and treatment
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • HER2/EGFR in Cancer Research
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • BRCA gene mutations in cancer
  • Cancer Cells and Metastasis
  • Advanced Breast Cancer Therapies
  • Breast Lesions and Carcinomas
  • Glioma Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Prostate Cancer Treatment and Research
  • Head and Neck Cancer Studies
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • PARP inhibition in cancer therapy
  • PARP inhibition in cancer therapy
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • PI3K/AKT/mTOR signaling in cancer
  • Angiogenesis and VEGF in Cancer
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Colorectal Cancer Treatments and Studies
  • PARP inhibition in cancer therapy
  • Colorectal Cancer Treatments and Studies
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Lymphoma Diagnosis and Treatment
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Cancer-related Molecular Pathways
  • Lung Cancer Research Studies
  • T-cell and B-cell Immunology
  • Epigenetics and DNA Methylation
  • Cancer, Hypoxia, and Metabolism
  • Glioma Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Pancreatic and Hepatic Oncology Research
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Angiogenesis and VEGF in Cancer
  • Angiogenesis and VEGF in Cancer
  • PI3K/AKT/mTOR signaling in cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Ferroptosis and cancer prognosis
  • Ferroptosis and cancer prognosis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: